NDC 50242-150 – Ocrevus
Ocrelizumab 300 mg/10mL · Injection · Intravenous
Product NDC50242-150
Product details
- Brand name
- Ocrevus
- Generic name
- Ocrelizumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761053
- Marketed since
- March 28, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD20-directed Cytolytic Antibody
Active ingredients
- Ocrelizumab 300 mg/10mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-150-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-150-01) / 10 mL in 1 VIAL, SINGLE-USE | Mar 28, 2017 |